Related Experiment Video

Updated: Jun 28, 2025

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

9.9K

Midbrain organoids-development and applications in Parkinson's disease

Hilary S Y Toh1, Xin Yi Choo1, Alfred Xuyang Sun1,2

  • 1Neuroscience & Behavioural Disorders Programme, Duke-NUS Medical School, 8 College Road, Singapore.

Oxford Open Neuroscience
|April 10, 2024
PubMed

Keywords:
Parkinsonbrain organoiddegenerationdisease modellingdopamine neuron

More Related Videos

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders07:40

Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders

Published on: April 14, 2017

20.6K
A Human Cerebral Organoid Model of Neural Cell Transplantation08:58

A Human Cerebral Organoid Model of Neural Cell Transplantation

Published on: July 21, 2023

1.2K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541